Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-057596
Filing Date
2005-03-22
Accepted
2005-03-22 15:38:59
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 1108747
2 RESTATED CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 15595
3 SECOND AMENDED AND RESTATED BYLAWS dex310.htm EX-3.10 159790
4 THIRD AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT dex1024.htm EX-10.24 11686
5 MASTER SERVICES AGREEMENT dex1035.htm EX-10.35 82489
6 PROJECT ADDENDUM DATED MARCH 7, 2005 dex1036.htm EX-10.36 20349
7 AGREEMENT FOR THE TRANSFER OF SPONSORS OBLIGATIONS dex1037.htm EX-10.37 7312
8 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1640
9 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6334
10 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6535
11 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2890
12 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2923
  Complete submission text file 0001193125-05-057596.txt   1429561
Mailing Address 75 FIFTH STREET, NW SUITE 313 ATLANTA GA 30308
Business Address 75 FIFTH STREET, NW SUITE 313 ATLANTA GA 30308 404-526-6200
CORAUTUS GENETICS INC (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15833 | Film No.: 05696747
SIC: 2836 Biological Products, (No Diagnostic Substances)